David Shibata

16.8k total citations
158 papers, 4.4k citations indexed

About

David Shibata is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, David Shibata has authored 158 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Oncology, 61 papers in Surgery and 37 papers in Molecular Biology. Recurrent topics in David Shibata's work include Colorectal Cancer Screening and Detection (33 papers), Colorectal Cancer Surgical Treatments (29 papers) and Colorectal and Anal Carcinomas (29 papers). David Shibata is often cited by papers focused on Colorectal Cancer Screening and Detection (33 papers), Colorectal Cancer Surgical Treatments (29 papers) and Colorectal and Anal Carcinomas (29 papers). David Shibata collaborates with scholars based in United States, Germany and Japan. David Shibata's co-authors include Erin M. Siegel, Glenn Steele, Stephen J. Meltzer, Florin M. Selaru, Ronald Bleday, Yuriko Mori, John Abraham, Jing Yin, Timothy J. Yeatman and Domenico Coppola and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

David Shibata

150 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Shibata United States 38 2.4k 1.4k 1.2k 754 660 158 4.4k
Timothy Perren United Kingdom 42 3.0k 1.2× 1.3k 1.0× 1.4k 1.1× 902 1.2× 806 1.2× 151 6.6k
Joseph Kim United States 40 2.5k 1.0× 1.2k 0.9× 1.1k 0.9× 1.0k 1.4× 405 0.6× 175 4.8k
Blasé N. Polite United States 32 3.3k 1.4× 1.0k 0.8× 733 0.6× 1.1k 1.5× 822 1.2× 164 4.9k
Ondřej Topolčan Czechia 31 1.6k 0.6× 622 0.5× 1.3k 1.1× 1.0k 1.4× 496 0.8× 254 4.2k
Heather Lin United States 40 2.2k 0.9× 949 0.7× 1.3k 1.0× 1.6k 2.1× 452 0.7× 173 4.9k
Helen Huang United States 30 2.9k 1.2× 2.7k 2.0× 1.3k 1.0× 1.1k 1.5× 745 1.1× 68 8.1k
Eric X. Chen Canada 42 2.5k 1.1× 1.6k 1.2× 1.8k 1.5× 1.6k 2.2× 532 0.8× 162 5.7k
Steven Gallinger Canada 38 2.2k 0.9× 1.0k 0.8× 1.1k 0.9× 690 0.9× 1.7k 2.6× 90 4.3k
Angeles Alvarez Secord United States 46 2.3k 1.0× 1.1k 0.8× 1.5k 1.2× 738 1.0× 580 0.9× 288 7.2k
Vincent Chung United States 30 2.3k 1.0× 646 0.5× 897 0.7× 631 0.8× 250 0.4× 169 3.6k

Countries citing papers authored by David Shibata

Since Specialization
Citations

This map shows the geographic impact of David Shibata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Shibata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Shibata more than expected).

Fields of papers citing papers by David Shibata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Shibata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Shibata. The network helps show where David Shibata may publish in the future.

Co-authorship network of co-authors of David Shibata

This figure shows the co-authorship network connecting the top 25 collaborators of David Shibata. A scholar is included among the top collaborators of David Shibata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Shibata. David Shibata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Byrd, Doratha A., Maria F. Gomez, Tengda Lin, et al.. (2025). The gut microbiome is associated with disease‐free survival in stage I–III colorectal cancer patients. International Journal of Cancer. 157(1). 64–73. 2 indexed citations
2.
Jeong, Daniel, A Richards, Maria F. Gomez, et al.. (2025). Comparison of volumetric and single-slice computed tomography body composition metrics for colorectal cancer survival. European Journal of Radiology. 190. 112241–112241.
3.
Fleming, Andrew M., Danny Yakoub, Nosratollah Nezakatgoo, et al.. (2024). CTNNB1 exon 3 mutations in metastatic solid pseudopapillary neoplasm of the pancreas. Journal of Surgical Oncology. 130(5). 1051–1061. 1 indexed citations
4.
Yu, Ming, Kelly Carter, Kelsey K. Baker, et al.. (2023). Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas. Cancer Epidemiology Biomarkers & Prevention. 32(9). 1146–1152. 3 indexed citations
5.
Kansal, Rita G., et al.. (2023). Bromo- and Extra-Terminal Domain Inhibitors Induce Mitochondrial Stress in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. 22(8). 936–946. 2 indexed citations
6.
Fleming, Andrew M., Zachary E. Stiles, Paxton V. Dickson, et al.. (2023). Lymph node metastases in young patients with gastrointestinal stromal tumor: A nationwide analysis. Journal of Surgical Oncology. 128(8). 1268–1277.
7.
Dickson, Paxton V., Evan S. Glazer, David Shibata, et al.. (2022). Visceral angiosarcoma: A nationwide analysis of treatment factors and outcomes. Journal of Surgical Oncology. 125(8). 1231–1237. 3 indexed citations
8.
Ose, Jennifer, Biljana Gigic, Sheetal Hardikar, et al.. (2022). Presurgery Adhesion Molecules and Angiogenesis Biomarkers Are Differently Associated with Outcomes in Colon and Rectal Cancer: Results from the ColoCare Study. Cancer Epidemiology Biomarkers & Prevention. 31(8). 1650–1660. 2 indexed citations
9.
VanderWalde, Noam A., et al.. (2021). Evolution and Current Status of the Multidisciplinary Management of Locally Advanced Rectal Cancer. JCO Oncology Practice. 17(7). 383–402. 11 indexed citations
10.
Schmitt, Felix C. F., Martin Schneider, Markus A. Weigand, et al.. (2021). Postoperative Complications Are Associated with Long-Term Changes in the Gut Microbiota Following Colorectal Cancer Surgery. Life. 11(3). 246–246. 11 indexed citations
11.
Stein, Matthew K., Joanne Xiu, Michael G. Martin, et al.. (2020). Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma. Journal of Surgical Oncology. 121(8). 1320–1328. 18 indexed citations
12.
Stiles, Zachary E., Louis J. Magnotti, Stephen W. Behrman, et al.. (2020). The impact of race and socioeconomic status on the presentation, management and outcomes for gastric cancer patients: Analysis from a metropolitan area in the southeast United States. Journal of Surgical Oncology. 121(3). 494–502. 9 indexed citations
13.
Gigic, Biljana, Johanna Nattenmüller, Martin Schneider, et al.. (2020). The Role of CT-Quantified Body Composition on Longitudinal Health-Related Quality of Life in Colorectal Cancer Patients: The Colocare Study. Nutrients. 12(5). 1247–1247. 13 indexed citations
14.
Konieczkowski, David J., Bhupendra Rawal, Brendan Reardon, et al.. (2019). The Genomic Landscape of Anal Cancer and Its Relationship to Clinical Outcomes: An Exploratory Analysis of NRG Oncology/RTOG 98-11. International Journal of Radiation Oncology*Biology*Physics. 105(1). S104–S105.
15.
Lewis, Richard H., Evan S. Glazer, Thomas R. OʼBrien, et al.. (2018). Outcomes Following Resection of Hepatocellular Carcinoma in the Absence of Cirrhosis. Journal of Gastrointestinal Cancer. 50(4). 808–815. 7 indexed citations
16.
Krasnick, Bradley A., Gustavo A. Miranda‐Carboni, Ryan C. Fields, et al.. (2018). IL23 and TGF-ß diminish macrophage associated metastasis in pancreatic carcinoma. Scientific Reports. 8(1). 5808–5808. 18 indexed citations
17.
Siegel, Erin M., et al.. (2017). Quantitative Assessment of Visceral Obesity and Postoperative Colon Cancer Outcomes. Journal of Gastrointestinal Surgery. 21(3). 534–542. 37 indexed citations
18.
Ladd, Jon J., Christopher I. Li, John D. Potter, et al.. (2016). Protein and glycomic plasma markers for early detection of adenoma and colon cancer. Gut. 67(3). 473–484. 61 indexed citations
19.
Hernandez, Jonathan M., Abul Elahi, W. Edwin Clark, et al.. (2015). The Tumor Suppressive Effects of HPP1 Are Mediated Through JAK-STAT-Interferon Signaling Pathways. DNA and Cell Biology. 34(8). 541–549. 10 indexed citations
20.
Siegel, Erin M., Anders Berglund, Steven A. Eschrich, et al.. (2014). Expanding Epigenomics to Archived FFPE Tissues: An Evaluation of DNA Repair Methodologies. Cancer Epidemiology Biomarkers & Prevention. 23(12). 2622–2631. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy Perren Breakdown of academic impact, for papers by Joseph Kim Breakdown of academic impact, for papers by Blasé N. Polite Breakdown of academic impact, for papers by Ondřej Topolčan Breakdown of academic impact, for papers by Heather Lin Breakdown of academic impact, for papers by Helen Huang Breakdown of academic impact, for papers by Eric X. Chen Breakdown of academic impact, for papers by Steven Gallinger Breakdown of academic impact, for papers by Angeles Alvarez Secord Breakdown of academic impact, for papers by Vincent Chung
Rankless by CCL
2026